How do hormones affect tumor DNA in men with breast cancer?

February 14, 2018, The Netherlands Cancer Institute

Breast cancer in men is rare, and men with breast cancer receive the same anti-hormonal therapy as women. Often with effect, but there was no scientific basis for it before now. Cancer researchers led by Wilbert Zwart from the Netherlands Cancer Institute and Oncode Institute are now the first to clarify how hormones affect tumor DNA in men with breast cancer.

Most tumors in men barely differ biologically from those in women. But in tumors that react badly to anti-hormonal , the researchers saw subtle differences between the two sexes. These new insights constitute another major step towards the best personalized treatment for men and women.

The researchers published their findings on February 2 in the scientific journal Nature Communications.

Therapy based on treatment of women

Approximately 100 men per year are diagnosed with breast cancer in the Netherlands, compared to more than 14,000 women. In the vast majority of breast cancers, both in men and women, the tumor is hormone-sensitive. This means that hormones, like estrogen, influence the DNA, causing the tumor to grow and eventually to spread. Anti-hormonal therapy, aimed at blocking the , is therefore also often part of the treatment for men. Often with effect but also with stressful side effects. However, there was not yet a scientific basis for giving men the same treatment as women. The researchers, led by Wilbert Zwart, have now mapped the hormonal function over the entire tumor DNA for the first time and compared men and women.

The first conclusion was that by far most of the breast tumors in men and women are barely distinguishable from each other. This provides a scientific basis for the current practice of giving men and women the same anti-hormonal therapy.

But as with women with hormone-sensitive , there are also men whose still comes back despite the treatment. This group is therefore likely to benefit from a different or supplementary approach. And it is precisely in this group of men that the DNA profiles of the tumor appear to be gender-specific.

Wilbert Zwart: "We had already seen that very specific patterns in women are predictive of the course of the disease. In patients with a less favorable course of the disease, other sites of the DNA are active under the influence of hormones. That says something about the therapy sensitivity of each individual and this knowledge is essential when looking for a personalized therapy. In men, we also see specific patterns that are different than in . If we are to work towards a personalized for men, the selection of medicines may, therefore, have to be slightly different. But a lot of research is still needed for this."

Explore further: Breast cancer treatment link to chronic disease

More information: Tesa M. Severson et al. Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer, Nature Communications (2018). DOI: 10.1038/s41467-018-02856-2

Related Stories

Breast cancer treatment link to chronic disease

January 16, 2018
Women who have undergone hormonal therapy for breast cancer are at increased risk of developing chronic conditions later in life, according to new research.

Pregnancy not dangerous for women who had breast cancer

June 4, 2017
Becoming pregnant after a diagnosis of breast cancer does not raise the risk of the cancer returning, said the largest study of its kind to date, released Saturday at a major cancer conference.

Soybean consumption may be beneficial for some women with breast cancer

June 21, 2017
It can be confusing to know what to eat to lower your risk of breast cancer. Research is mixed, for example, on whether women should avoid soy foods, such as tofu and soybeans, or try to eat more of them. The question is ...

Estrogen plus progestin use linked with increased breast cancer incidence and mortality

March 29, 2013
Estrogen plus progestin use is linked with increased breast cancer incidence. In addition, prognosis is similar for both users and nonusers of combined hormone therapy, suggesting that mortality from breast cancer may be ...

Stopping hormones might help breast cancer to regress

February 28, 2012
As soon as women quit hormone therapy, their rates of new breast cancer decline, supporting the hypothesis that stopping hormones can lead to tumor regression, according to a report e-published in Cancer Epidemiology, Biomarkers, ...

Pregnancy after breast cancer does not increase chance of recurrence

June 5, 2017
Findings from a retrospective study of 1,200 women provide reassurance to breast cancer survivors who are contemplating pregnancy. In the study, women who became pregnant after an early breast cancer diagnosis, including ...

Recommended for you

Fully reprogrammed virus offers new hope as cancer treatment

May 25, 2018
A cancer treatment that can completely destroy cancer cells without affecting healthy cells could soon be a possibility, thanks to research led by Cardiff University.

Research could help fine-tune cancer treatment

May 25, 2018
Cancer therapies that cut off blood supply to a tumour could be more effective in combination with existing chemotherapeutic drugs—according to new research from the University of East Anglia.

Increasing physical activity linked to better immunity in breast cancer patients, study finds

May 25, 2018
A new study from the University of Toronto's Faculty of Kinesiology & Physical Education has found that moderate to vigorous physical activity may help regulate the levels of C-reactive protein – an important biomarker ...

Low-fat diet tied to better breast cancer survival

May 24, 2018
(HealthDay)—Breast cancer patients who adopted a low-fat diet were more likely to survive for at least a decade after diagnosis, compared to patients who ate fattier fare, new research shows.

A cascade of immune processes offers insights to triple-negative breast cancer

May 24, 2018
Cancer is crafty. To survive and thrive, tumors find a way of thwarting our body's natural systems.

By forming clots in tumors, immune cell aids lung cancer's spread

May 24, 2018
University of North Carolina Lineberger Comprehensive Cancer Center researchers have found that by helping to form clots within tumors, immune cells that flock to a particular type of lung cancer are actually building a foundation ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.